Johnson & Johnsonreason 03 of 4it owns a thing that cannot be built or permitted twicederived 2026-09-11accession 0000200406-26-000153
MedTech segment sales in the fiscal six months of 2026 were $17.6 billion, an increase of 6.0% as compared to the same period a year ago, with an operational increase of 4.1%
Electrophysiology sales growth was driven by procedure growth, commercial execution and new product performance (VARIPULSE, TRUPULSE, NUVISION and CRYSTAL)
Shockwave sales growth was driven by strong adoption of Coronary and Peripheral portfolios and new product launches
In October 2025, the Company announced its intention to separate its Orthopaedics business
no findingread · nothing bore on it
It held on this filing. No finding was written because nothing in it bore on the reason — the sentences it was read against are below.
the evidence · every sentence checkedfour sentences · whole, uncut
the claims it rests on
“MedTech segment sales in the fiscal six months of 2026 were $17.6 billion, an increase of 6.0% as compared to the same period a year ago, with an operational increase of 4.1%”
“Electrophysiology sales growth was driven by procedure growth, commercial execution and new product performance (VARIPULSE, TRUPULSE, NUVISION and CRYSTAL)”
“Shockwave sales growth was driven by strong adoption of Coronary and Peripheral portfolios and new product launches”
“In October 2025, the Company announced its intention to separate its Orthopaedics business”